Review Series - March 8, 2018

Strategies to Improve GVL Effects

Introduced with an editorial by Blood Associate Editor Robert Zeiser, this review series explores exciting new developments in treatments to enhance graft-versus-leukemia (GVL) effects in hematopoietic cell transplantation, including cellular therapies, antibody-based treatments, and drug-based approaches using tyrosine kinase inhibitors and checkpoint blockade.

Robert Zeiser, MD, and Michel Sadelain, MD, PhD discuss highlights of this review series.


Review Series Articles: